GlassScriptPhysician profile
Thomas W Herendeen
NPI 1356333272
$2,057.90
in general payments reported to CMS, 2019-2025
26 companies · $541 in 2025
The $541 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $61.41 · 2020: $165 · 2021: $162 · 2022: $149 · 2023: $409 · 2024: $571 · 2025: $541.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,521.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,520.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $427.34 | 2023-2025 | |
| Stryker Corporation | $276.10 | 2019-2024 | Sonopet Iq, Core |
| Glaxosmithkline, LLC. | $230.25 | 2022-2024 | Nucala |
| Abbvie INC. | $141.10 | 2024 | |
| Aerin Medical INC. | $139.96 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $136.03 | 2024-2025 | Dupixent |
| Optinose US, INC. | $133.89 | 2019-2024 | |
| Inspire Medical Systems, INC. | $77.31 | 2024-2025 | Inspire |
| Acclarent, INC | $76.30 | 2021-2023 | Relieva Spinplus |
| Organogenesis INC. | $49.13 | 2021 | |
| Amgen INC. | $45.17 | 2025 | Uplizna |
| Integra Lifesciences Corporation | $34.26 | 2025 | Relieva Spinplus Nav, Trudi Probe, Inspira Air |
| Pfizer INC. | $33.50 | 2024 | |
| Sanara Medtech INC. | $28.26 | 2021 | |
| Pharming Healthcare, INC. | $27.90 | 2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $25.96 | 2021-2022 | |
| Tactile Systems Technology INC | $25.49 | 2019 | |
| Smith+Nephew, INC. | $24.71 | 2021 | |
| Medtronic, INC. | $18.68 | 2024 | Ligasure |
| E.R. Squibb & Sons, L.L.C. | $17.68 | 2020 | |
| Alk-Abello, INC | $17.32 | 2025 | Pre-Pen |
| Hologic Sales and Service, LLC | $16.11 | 2024 | Coolseal Generator |
| Mimedx Group, INC. | $14.81 | 2024 | |
| Astrazeneca Pharmaceuticals LP | $14.59 | 2025 | Tezspire |
| Kowa Pharmaceuticals America, INC. | $13.13 | 2022 | |
| Allergan, INC. | $12.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Herendeen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.